Linda Phung joined the Reagan-Udall Foundation for the FDA as a Research Associate in April of 2024. In her role, she will work as a part of the Innovation in Medical Evidence and Development Surveillance (IMEDS) team as well as contribute to research pertaining to substance use disorders.

Prior to joining the Foundation, Phung worked at the Center for Food as Medicine of CUNY Hunter College as a Research Assistant and Lawndale Christian Health Center in Chicago, IL as a Medical Operations Assistant. She was also a health policy intern for nonprofits, C3 Collaborating for Health and The Centre for Ageing Better, in London. Before her days in public health, Phung was a Research Assistant in the Geoffrey Greene Lab, where she studied the effect of the repurposed selective estrogen receptor modulator, Lasofoxifene, on ER+ breast cancer.

Phung has a bachelor’s degree in Biology with a specialization in cancer biology from The University of Chicago and a master’s degree in Public Health from New York University with a concentration in Global Health. In her free time, she enjoys cycling, trying new restaurants, and taking her dog on long walks.